AL MOMENTO ESAURITO

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia by Masahiro Kizaki (Hardcover, 2015)

Prodotto più venduto in Università e adulti

Diapositiva attuale {CURRENT_SLIDE} di {TOTAL_SLIDES}- Prodotto più venduto in Università e adulti

Ragnarok
Nessun punteggio o recensione
EUR 5,20 Novità
---- usato
Il libro completo delle aperture. Apprendere bene e velocemente le mosse, i piani, le idee
Nessun punteggio o recensione
EUR 30,00 Novità
EUR 30,00 usato
Invito all'amore
Nessun punteggio o recensione
EUR 5,00 Novità
---- usato
Fare progettazione. La «pratica» di un percorso didattico per la comprensione significativa
Nessun punteggio o recensione
EUR 26,00 Novità
---- usato
Gente indipendente
Nessun punteggio o recensione
EUR 19,50 Novità
---- usato
Piano. 1º livello
5.0 stelle su 5, in base a 1 recensione del prodotto
EUR 14,66 Novità
EUR 1,00 usato
Sergej Prokofiev. La vita, la poetica, lo stile
Nessun punteggio o recensione
EUR 20,00 Novità
EUR 14,50 usato

Diapositiva attuale {CURRENT_SLIDE} di {TOTAL_SLIDES}- Risparmia su Università e adulti

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development. Included are therapeutic implications, diagnosis, and prognosis for understanding and facilitating daily practice in the management of patients with CML. Understanding of the pathogenesis and therapy of hematological malignancies such as CML has grown significantly in recent years. This development owe much to the progress in molecular biology and now makes a major contribution to diagnosis and to treatment that pharmacologically targets the molecular events of CML. Molecular targeting therapy with newly developed agents such as small molecules and antibodies for hematological malignancies are being discovered after years of research. Some of these, including tyrosine kinase inhibitors such as imatinib, nilotinib, and dasatinib, lead to increased survival rates and improved therapies. With the opinion leaders of basic and clinical research in the field as authors, this book reviews recent advances in the biology of CML.

Author
Masahiro Kizaki
Publication Name
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
Format
Hardcover
Language
English
Subject
Medicine
Publication Year
2015
Type
Textbook
Number of Pages
193 Pages